Inactive Instrument

Analyst Reco. LabStyle Innovations Corp Nasdaq

Equities

US50544T3023

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

Alliance Global Adjusts Price Target on DarioHealth to $4.10 From $5.45, Keeps Buy Rating	11/23/11	MT
Stifel Nicolaus Adjusts DarioHealth Price Target to $6 From $9, Maintains Buy Rating	25/23/25	MT
Craig-Hallum Adjusts DarioHealth's Price Target to $8 From $14, Keeps Buy Rating	12/23/12	MT
Alliance Global Partners Adjusts Price Target on DarioHealth to $7.50 From $9.15, Maintains Buy Rating	16/22/16	MT
Aegis Capital Adjusts DarioHealth's Price Target to $15 from $20, Keeps Buy Rating	18/22/18	MT
Stifel Nicolaus Adjusts DarioHealth Price Target to $11 From $15, Maintains Buy Rating	16/22/16	MT
Cowen Adjusts Trims Price Target on DarioHealth to $14 From $18, Keeps Outperform Rating	16/22/16	MT
Craig-Hallum Lowers Price Target for DarioHealth to $14 From $18, Maintains Buy Rating	16/22/16	MT
Aegis Capital Adjusts DarioHealth's Price Target to $20 from $23, Keeps Buy Rating	16/22/16	MT
Cowen Adjusts DarioHealth's Price Target to $18 from $14, Keeps Outperform Rating	16/22/16	MT
Alliance Global Upgrades DarioHealth to Buy From Neutral, Keeps $8.75 Price Target	13/22/13	MT
Aegis Capital Adjusts DarioHealth Price Target to $25 From $28, Maintains Buy Rating	26/22/26	MT
DARIOHEALTH : Aegis Capital Adjusts Price Target on DarioHealth to $28 From $35, Maintains Buy Rating	19/21/19	MT
DARIOHEALTH : Cantor Fitzgerald Adjusts DarioHealth's Price Target to $30 from $35, Keeps Overweight Rating	17/21/17	MT
DARIOHEALTH : Alliance Global Adjusts DarioHealth's Price Target to $12.75 From $15.25, Maintains Neutral Rating	17/21/17	MT
DARIOHEALTH : Alliance Global Adjusts DarioHealth's Price Target to $15.25 From $18.25, Maintains Neutral Rating	24/21/24	MT
DARIOHEALTH : Cowen Starts DarioHealth at Outperform With $31 Price Target	22/21/22	MT
DARIOHEALTH : Stifel Starts DarioHealth at Buy With $30 Price Target	23/21/23	MT
DARIOHEALTH : Cantor Fitzgerald Starts DarioHealth at Overweight With $35 Price Target	25/21/25	MT
DARIOHEALTH : Alliance Global Partners Downgrades DarioHealth to Neutral From Buy, Adjusts PT to $22.25 From $15.60	02/21/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. LabStyle Innovations Corp Nasdaq

Equities

US50544T3023

Analyst Reco.

Filters